- Dr. Michael Braun
- Director Late Stage Drug Product Development
- Boehringer Ingelheim Pharma, Germany
Dr Braun is a trained pharmacist with more than 15 years of experience in Drug Product Development. He received his Ph.D. in Pharmaceutical Technology at the University of Bonn and started his career in
pharmaceutical industry as Head of Pharmaceutical Development at Rentschler Pharma. In 2006 Michael joined Boehringer Ingelheim and worked in different positions with increasing responsibility within Pharmaceutical Development and R&D Project Management.
Since 2014 he is Director Late Stage Drug Product Development and responsible for process development and scale-up of solid and liquid orals, parenterals and inhalative NCE products. This also includes product transfers to operations, launch support and preparation of submission documentation.
- Dr. Sid Mujumdar
- Group Head Late Stage Pharmaceutical Development
- Hoffmann-La Roche, Switzerland
Dr Mujumdar is a pharmaceutical scientist with more than 10 years of experience in Drug Product Development across the US and EU. He received his Ph.D. in Biomedical Engineering from the University of Minnesota and has previously worked in drug produce development at Boehringer Ingelheim, US (early and late NCE development) and Novartis Pharma, Basel (Continuous Manufacturing technology development). Currently, he is a Group Head and Project Leader at Hoffmann-La. Roche, Basel in Late Stage Pharmaceutical development, responsible for market formulation development, scale up and transfer of solid and liquid oral NCE formulations, including tech transfers, filing and process validation activities.